Related Experiment Video
Updated: Aug 16, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus
1Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China. ronbin@ha.mc.ntu.edu.tw
Background And Objective:
Nosocomial infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are increasing. Only a few studies of MRSA infective endocarditis have been conducted, and none have reported its risk factors. We sought to determine the host-related risk factors for infective endocarditis in patients with nosocomial MRSA bacteremia.
Setting:
A 2,000-bed, university-affiliated, tertiary-care hospital.
Patients:
Thirty-one patients with nosocomial MRSA infective endocarditis between October 1996 and May 2003.
Design:
A retrospective chart review was conducted. Data were compared with those from a control group of patients with nosocomial MRSA bacteremia. Logistic regression was used to identify independent risk factors for nosocomial infective endocarditis.
Results:
Compared with patients who had nosocomial MRSA bacteremia and no infective endocarditis, patients who had infective endocarditis had a higher incidence of chronic liver disease and a lower incidence of immunodeficiency. The risk of developing infective endocarditis was approximately 10% for patients with nosocomial MRSA bacteremia.
Conclusion:
Patients with MRSA bacteremia and underlying chronic liver disease were prone to infective endocarditis.
Insights
Patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and chronic liver disease face a higher risk of developing MRSA infective endocarditis. This study identified key host-related risk factors for this serious nosocomial infection.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Epidemiology
Background:
- Rising incidence of nosocomial infections attributed to methicillin-resistant Staphylococcus aureus (MRSA).
- Limited research on MRSA infective endocarditis, with no prior identification of risk factors.
- Urgent need to understand host-related factors predisposing to MRSA infective endocarditis.
Purpose of the Study:
- To identify host-related risk factors for infective endocarditis in patients with hospital-acquired MRSA bacteremia.
- To elucidate the specific vulnerabilities that increase the likelihood of developing MRSA infective endocarditis.
Main Methods:
- Retrospective chart review at a tertiary-care hospital.
- Comparison of patients with and without infective endocarditis among those with nosocomial MRSA bacteremia.
- Logistic regression analysis to determine independent risk factors.
Main Results:
- Patients with MRSA infective endocarditis exhibited a higher prevalence of chronic liver disease.
- A lower incidence of immunodeficiency was observed in patients with MRSA infective endocarditis.
- The overall risk of developing infective endocarditis from nosocomial MRSA bacteremia was approximately 10%.
Conclusions:
- Chronic liver disease is a significant risk factor for developing infective endocarditis in patients with MRSA bacteremia.
- Immunodeficiency appears to be a protective factor against MRSA infective endocarditis in this patient population.
- Targeted surveillance and preventive strategies may be warranted for MRSA bacteremic patients with underlying chronic liver disease.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Endocarditis I: Introduction
Staphylococcal Skin Infections
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis III: Medical Management
